Use of Lactoferrin in the Treatment of Patients with Severe Concomitant Injury

Objective: to define the degree of activation of lipid peroxidation in patients with severe concomitant injury and to determine whether they could be corrected with the antioxidant agent Laprot. Subjects and methods. The time course of changes in lipid peroxidation parameters and clinical data was s...

Full description

Saved in:
Bibliographic Details
Main Authors: V. M. Kapitonov, D. A. Ostapchenko, Ye. R. Nemtsova
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2009-10-01
Series:Общая реаниматология
Online Access:https://www.reanimatology.com/rmt/article/view/529
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849698688429981696
author V. M. Kapitonov
D. A. Ostapchenko
Ye. R. Nemtsova
author_facet V. M. Kapitonov
D. A. Ostapchenko
Ye. R. Nemtsova
author_sort V. M. Kapitonov
collection DOAJ
description Objective: to define the degree of activation of lipid peroxidation in patients with severe concomitant injury and to determine whether they could be corrected with the antioxidant agent Laprot. Subjects and methods. The time course of changes in lipid peroxidation parameters and clinical data was studied in 68 patients with severe concomitant injury, in 35 of whom Laprot (made by P. A. Herzen Moscow Oncological Research Institute, Russian Agency for Medical Technologies (Russia), was added to the standard treatment. Results. The significant activation of oxidative processes and lipid peroxi-dation, which was accompanied by antioxidant system imbalance, was ascertained to occur in severe concomitant injury. Key words: injury, lipid peroxidation, lactoferrin.
format Article
id doaj-art-00e9fa54d9a34bdf89c732a3bd9d123d
institution DOAJ
issn 1813-9779
2411-7110
language English
publishDate 2009-10-01
publisher Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
record_format Article
series Общая реаниматология
spelling doaj-art-00e9fa54d9a34bdf89c732a3bd9d123d2025-08-20T03:18:50ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102009-10-015510.15360/1813-9779-2009-5-10529Use of Lactoferrin in the Treatment of Patients with Severe Concomitant InjuryV. M. KapitonovD. A. OstapchenkoYe. R. NemtsovaObjective: to define the degree of activation of lipid peroxidation in patients with severe concomitant injury and to determine whether they could be corrected with the antioxidant agent Laprot. Subjects and methods. The time course of changes in lipid peroxidation parameters and clinical data was studied in 68 patients with severe concomitant injury, in 35 of whom Laprot (made by P. A. Herzen Moscow Oncological Research Institute, Russian Agency for Medical Technologies (Russia), was added to the standard treatment. Results. The significant activation of oxidative processes and lipid peroxi-dation, which was accompanied by antioxidant system imbalance, was ascertained to occur in severe concomitant injury. Key words: injury, lipid peroxidation, lactoferrin.https://www.reanimatology.com/rmt/article/view/529
spellingShingle V. M. Kapitonov
D. A. Ostapchenko
Ye. R. Nemtsova
Use of Lactoferrin in the Treatment of Patients with Severe Concomitant Injury
Общая реаниматология
title Use of Lactoferrin in the Treatment of Patients with Severe Concomitant Injury
title_full Use of Lactoferrin in the Treatment of Patients with Severe Concomitant Injury
title_fullStr Use of Lactoferrin in the Treatment of Patients with Severe Concomitant Injury
title_full_unstemmed Use of Lactoferrin in the Treatment of Patients with Severe Concomitant Injury
title_short Use of Lactoferrin in the Treatment of Patients with Severe Concomitant Injury
title_sort use of lactoferrin in the treatment of patients with severe concomitant injury
url https://www.reanimatology.com/rmt/article/view/529
work_keys_str_mv AT vmkapitonov useoflactoferrininthetreatmentofpatientswithsevereconcomitantinjury
AT daostapchenko useoflactoferrininthetreatmentofpatientswithsevereconcomitantinjury
AT yernemtsova useoflactoferrininthetreatmentofpatientswithsevereconcomitantinjury